MktsMarkets

Veracyte, Inc.
NASDAQ: VCYTKey statistics
VCYT News
Stories mentioning VCYT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 139,071 | 140,636 | 131,872 | 130,164 | 114,473 | 118,632 | 115,860 | 114,428 |
| Cost of Goods Sold | ||||||||
| Gross Profit | 101,159 | 101,973 | 91,282 | 89,769 | 79,508 | 78,754 | 79,010 | 77,913 |
| Operating Expenses | ||||||||
| Research & Development | 27,098 | 20,849 | 15,981 | 16,264 | 17,720 | 19,290 | 17,574 | 16,465 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 22,646 | 37,195 | 22,946 | (5,268) | 2,904 | 4,175 | 12,017 | 4,606 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 7,328 | 3,439 | (4,057) | 6,518 | 4,524 | (732.00) | 4,831 | 2,755 |
| Pretax Income | 29,974 | 40,634 | 18,889 | 1,250 | 7,428 | 3,443 | 16,848 | 7,361 |
| Tax Provision | 1,267 | (515.00) | (248.00) | 2,230 | 381.00 | (1,670) | 1,693 | 1,627 |
| Net Income (Loss) | 28,707 | 41,149 | 19,137 | (980.00) | 7,047 | 5,113 | 15,155 | 5,734 |
| Earnings Per Share (Basic) | 0.36 | 0.52 | 0.24 | (0.01) | 0.09 | 0.07 | 0.20 | 0.07 |
| Earnings Per Share (Diluted) | 0.35 | 0.51 | 0.24 | (0.01) | 0.09 | 0.07 | 0.19 | 0.07 |
| Weighted Average Shares Outstanding (Basic) | 79,537 | 78,584 | 78,725 | 78,392 | 78,028 | 76,485 | 77,014 | 76,538 |
| Weighted Average Shares Outstanding (Diluted) | 81,314 | 80,573 | 79,692 | 78,392 | 80,056 | 78,163 | 78,465 | 77,163 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VCYT
Veracyte, Inc. (NASDAQ: VCYT) is a stock listed on the Nasdaq Stock Market under the ticker symbol VCYT. It last traded at $25.57 (Nov 18, 2026, 4:00 PM ET), up 5.5% on the day. That gives Veracyte a market capitalisation of $1.9B and a price-to-earnings ratio of 16.4.
Over the past 52 weeks VCYT has traded between $21.91 and $60.91.
Revenue for the quarter ended Mar 31, 2026 was $139.1M; net income $28.7M. Revenue was up 21.5% from $114.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $139.1M | $28.7M | 20.6% |
| Dec 31, 2025 | $140.6M | $41.1M | 29.3% |
| Sep 30, 2025 | $131.9M | $19.1M | 14.5% |
| Jun 30, 2025 | $130.2M | -$980.0K | -0.8% |
From Veracyte’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…